4 results
The primary objective of this first-in-man safety and feasibility study is to assess the safety of the Volcano PreView FL.IVUS catheter when used after successful coronary stenting.
The objective of this study is to perform a non-inferiority analysis of drug-eluting balloons (DEB) with provisional stenting and primary stenting with drug-eluting stents (DES) in the treatment of femoropopliteal arterial occlusive disease. If DEB…
DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild hemophilia A.
Primary objectives:To assess the proportion of non-severe hemophilia A patients within FVIII target levels with the DDAVP and FVIII concentrate combination treatment in the first 72 hours after the start of combination treatment, without adding off-…
This study is being conducted to determine the safety and efficacy of the study drug BIVV001 when used as a once-a-week prophylaxis treatment or as an on-demand (as-needed) treatment for bleeding in patients 12 years and older with severe hemophilia…